We Can Medicines Co., Ltd. (TPEX:6929)
32.00
-0.05 (-0.16%)
Apr 25, 2025, 11:55 AM CST
We Can Medicines Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 305.67 | 160.53 | 216.26 | 203.36 | 120.18 |
Trading Asset Securities | - | - | - | - | 150 |
Cash & Short-Term Investments | 305.67 | 160.53 | 216.26 | 203.36 | 270.18 |
Cash Growth | 90.42% | -25.77% | 6.34% | -24.73% | - |
Accounts Receivable | 178.05 | 225.54 | 142 | 127.47 | 72.93 |
Other Receivables | 40.75 | 40.05 | 27.98 | 26.08 | 14.31 |
Receivables | 218.8 | 265.59 | 169.98 | 153.55 | 87.24 |
Inventory | 850.88 | 776.83 | 690.45 | 583.97 | 529.88 |
Prepaid Expenses | 87.82 | 87.96 | 75.79 | 52.49 | 50.13 |
Other Current Assets | 1.45 | 0.63 | 2.16 | 1.55 | 1.08 |
Total Current Assets | 1,465 | 1,292 | 1,155 | 994.92 | 938.51 |
Property, Plant & Equipment | 1,562 | 1,515 | 1,370 | 1,150 | 764.48 |
Other Intangible Assets | 6.95 | 3.87 | 4.97 | 9.38 | 10.15 |
Long-Term Deferred Tax Assets | 0.53 | 0.6 | 1.19 | 16.82 | 16.82 |
Other Long-Term Assets | 51.38 | 50.22 | 44.9 | 39.13 | 36.27 |
Total Assets | 3,086 | 2,861 | 2,576 | 2,210 | 1,766 |
Accounts Payable | 507.36 | 540.01 | 517.49 | 443.55 | 291.34 |
Accrued Expenses | 23.02 | 21.46 | 17.35 | 16.66 | - |
Short-Term Debt | - | 135 | - | - | - |
Current Portion of Long-Term Debt | 7.14 | 7.07 | 6.25 | - | - |
Current Portion of Leases | 233.38 | 210.29 | 198.68 | 173.38 | 159.87 |
Current Income Taxes Payable | - | 4.93 | 5.44 | - | - |
Current Unearned Revenue | 8.23 | 7.44 | 10.87 | 12.5 | 14.48 |
Other Current Liabilities | 142.25 | 118.9 | 144.27 | 130.02 | 127.07 |
Total Current Liabilities | 921.39 | 1,045 | 900.34 | 776.11 | 592.75 |
Long-Term Debt | 130.63 | 137.71 | 143.75 | 150 | - |
Long-Term Leases | 870.13 | 826.51 | 708.58 | 567.47 | 497.09 |
Other Long-Term Liabilities | 41.5 | 31.26 | 27.09 | 24.17 | 22.15 |
Total Liabilities | 1,969 | 2,045 | 1,784 | 1,526 | 1,121 |
Common Stock | 448.54 | 400 | 400 | 400 | 400 |
Additional Paid-In Capital | 666.43 | 353.53 | 343.55 | 339.45 | 339.45 |
Retained Earnings | 1.19 | 62.82 | 48.14 | -54.91 | -93.92 |
Shareholders' Equity | 1,116 | 816.35 | 791.69 | 684.54 | 645.52 |
Total Liabilities & Equity | 3,086 | 2,861 | 2,576 | 2,210 | 1,766 |
Total Debt | 1,241 | 1,317 | 1,057 | 890.85 | 656.96 |
Net Cash (Debt) | -935.62 | -1,156 | -841 | -687.49 | -386.78 |
Net Cash Per Share | -21.53 | -27.36 | -20.16 | -17.19 | -12.07 |
Filing Date Shares Outstanding | 44.85 | 40 | 40 | 40 | 32.04 |
Total Common Shares Outstanding | 44.85 | 40 | 40 | 40 | 32.04 |
Working Capital | 543.24 | 246.44 | 254.29 | 218.81 | 345.77 |
Book Value Per Share | 24.88 | 20.41 | 19.79 | 17.11 | 20.15 |
Tangible Book Value | 1,109 | 812.48 | 786.72 | 675.16 | 635.37 |
Tangible Book Value Per Share | 24.73 | 20.31 | 19.67 | 16.88 | 19.83 |
Land | 217.03 | 217.03 | 217.03 | 217.03 | 3.19 |
Buildings | 76.49 | 76.49 | 76.49 | 76.49 | 13.25 |
Machinery | 30.02 | 27.62 | 29.14 | 21.67 | 9.66 |
Construction In Progress | 0.68 | 4.4 | 2.49 | 3.5 | 1.41 |
Leasehold Improvements | 387.76 | 345.44 | 304.32 | 232.24 | 199.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.